PARATI, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 60.640
EU - Europa 24.553
AS - Asia 11.830
SA - Sud America 275
AF - Africa 85
OC - Oceania 77
Continente sconosciuto - Info sul continente non disponibili 43
Totale 97.503
Nazione #
US - Stati Uniti d'America 59.752
CN - Cina 4.314
SG - Singapore 4.096
IE - Irlanda 4.043
SE - Svezia 4.025
IT - Italia 3.912
RU - Federazione Russa 3.438
DE - Germania 3.416
UA - Ucraina 2.248
HK - Hong Kong 1.875
GB - Regno Unito 1.244
CA - Canada 813
FI - Finlandia 670
VN - Vietnam 534
FR - Francia 406
IN - India 249
NL - Olanda 218
TR - Turchia 209
AT - Austria 205
DK - Danimarca 199
ID - Indonesia 168
BR - Brasile 136
BE - Belgio 122
JP - Giappone 89
AU - Australia 64
ES - Italia 64
IR - Iran 62
KR - Corea 56
PL - Polonia 50
CZ - Repubblica Ceca 47
RO - Romania 47
MX - Messico 43
CH - Svizzera 38
PT - Portogallo 34
PE - Perù 32
CL - Cile 31
TH - Thailandia 31
EU - Europa 28
AR - Argentina 23
TW - Taiwan 23
ZA - Sudafrica 22
GR - Grecia 21
BG - Bulgaria 20
HU - Ungheria 20
CO - Colombia 19
BD - Bangladesh 18
NO - Norvegia 15
PK - Pakistan 15
MY - Malesia 13
AE - Emirati Arabi Uniti 12
BO - Bolivia 12
EG - Egitto 11
NZ - Nuova Zelanda 11
VE - Venezuela 11
A2 - ???statistics.table.value.countryCode.A2??? 10
NG - Nigeria 10
EC - Ecuador 9
IL - Israele 9
LT - Lituania 8
SA - Arabia Saudita 8
AM - Armenia 7
BY - Bielorussia 7
KE - Kenya 7
NP - Nepal 7
PH - Filippine 7
SC - Seychelles 7
BB - Barbados 6
GE - Georgia 6
RS - Serbia 6
DZ - Algeria 5
JO - Giordania 5
LK - Sri Lanka 5
AL - Albania 4
CR - Costa Rica 4
GT - Guatemala 4
HR - Croazia 4
LV - Lettonia 4
PA - Panama 4
SI - Slovenia 4
A1 - Anonimo 3
CU - Cuba 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GH - Ghana 3
MA - Marocco 3
MK - Macedonia 3
MU - Mauritius 3
AP - ???statistics.table.value.countryCode.AP??? 2
CM - Camerun 2
IQ - Iraq 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MD - Moldavia 2
MG - Madagascar 2
PG - Papua Nuova Guinea 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
Totale 97.481
Città #
Ann Arbor 10.712
Fairfield 6.278
Woodbridge 4.686
Dublin 3.857
Chandler 3.818
Houston 3.708
Singapore 3.326
Ashburn 3.130
Wilmington 2.971
Frankfurt am Main 2.714
Jacksonville 2.604
Seattle 2.291
Cambridge 2.082
Dearborn 2.041
Hong Kong 1.851
New York 1.831
Princeton 1.739
Santa Clara 1.635
Milan 1.073
Lawrence 833
Nanjing 793
Altamura 785
Beijing 588
San Diego 500
Shanghai 439
Lachine 375
Dong Ket 303
Boardman 273
Hangzhou 259
Nanchang 243
Shenyang 239
Guangzhou 237
Andover 235
Toronto 197
Helsinki 196
Vienna 187
Hebei 180
London 164
Jakarta 153
Jiaxing 147
Norwalk 147
Ottawa 142
Tianjin 137
Changsha 125
Falls Church 118
Jinan 110
Brussels 109
Rome 99
Mountain View 86
Huizen 84
Lappeenranta 82
Los Angeles 77
Fremont 76
Zhengzhou 76
Hefei 75
Kunming 68
Detroit 63
Washington 63
Chicago 59
Dallas 59
Ningbo 55
Phoenix 51
Munich 43
Pune 43
Redmond 43
Saint Petersburg 43
Taizhou 43
Edmonton 42
Perugia 42
San Mateo 42
Kilburn 40
Moscow 39
Amsterdam 33
Bologna 31
Brno 31
Sacramento 31
São Paulo 30
Turin 30
Fuzhou 28
Wuhan 28
Chiswick 27
Groningen 27
Kiev 26
Tokyo 26
University Park 26
Clearwater 25
Bergamo 24
Bonndorf 24
Kraków 24
Leawood 24
Hounslow 23
Naples 23
Verona 23
San Francisco 22
Cinisello Balsamo 21
Berlin 20
Belo Horizonte 19
Taiyuan 19
Bangkok 18
Florence 18
Totale 72.755
Nome #
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 400
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 398
May Measurement Month 2017: an analysis of blood pressure screening results worldwide 382
Endothelin-1/nitric oxide balance and HOMA index in children with excess weight and hypertension: a pathophysiological model of hypertension 357
The impact of systolic and diastolic blood pressure variability on mortality is age dependent: Data from the Dublin Outcome Study 345
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 322
Effect of continuous positive airway pressure in hypertensive patients with obstructive sleep apnea and high urinary metanephrines 307
Nation-wide hypertension screening in Italy: data from May Measurements Month 2017-Europe 298
Aldosterone-To-renin ratio depends on age and sex in children attending a clinic for cardiovascular risk assessment 289
Comprehensive effects of left ventricular assist device speed changes on alveolar gas exchange, sleep ventilatory pattern, and exercise performance 282
Impact of obstructive sleep apnea on cardiac organ damage in patients with acute ischemic stroke 279
Nomograms to identify elevated blood pressure values and left ventricular hypertrophy in a paediatric population: American Academy of Pediatrics Clinical Practice vs. Fourth Report/European Society of Hypertension Guidelines 279
Calcium antagonists and neural control of circulation in essential hypertension 268
Effects of acute exposure to moderate altitude on blood pressure and sleep breathing patterns 263
Changes in 24 hour blood pressure and in cardiac and vascular structure in normotensive subjects with parental hypertension 259
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 255
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension 253
An ICT and mobile health integrated approach to optimize patients' education on hypertension and its management by physicians: The Patients Optimal Strategy of Treatment(POST) pilot study 246
Home blood pressure telemonitoring improves hypertension control in general practice. the TeleBPCare study 245
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 243
Morning blood pressure surge: pathophysiology, clinical relevance and therapeutic aspects 243
Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the european society of cardiology, the council on hypertension of the european society of cardiology, the european society of hypertension, the international society of mountain medicine, the Italian society of hypertension and the Italian society of mountain medicine 242
European society of hypertension guidelines for blood pressure monitoring at home: A summary report of the second international consensus conference on home blood pressure monitoring 240
Transthoracic bioimpedance and bnp assessment for prognostic stratification of outpatients with chronic systolic heart failure. 239
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 238
Blood pressure variability and obstructive sleep apnea. A question of phenotype? 230
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 228
Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans 224
Cap. 8: Cuore e malattie sistemiche 222
Different effects of antihypertensive treatment on office and ambulatory blood pressure: Ameta-analysis 219
Role of T1 mapping as a complementary tool to T2* for non-invasive cardiac iron overload assessment 217
Effects of lifestyle modifications on elevated blood pressure and excess weight in a population of Italian children and adolescents 217
Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test 217
Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis 216
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 215
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 214
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 214
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 212
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: Meta-analysis of randomised controlled trials 210
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 209
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 207
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period 206
Noninvasive Estimation of Aortic Stiffness Through Different Approaches: Comparison with Intra-Aortic Recordings 203
Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: evidence against potentiation of baroreflexes 202
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 202
Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients 202
High altitude exposure of three weeks duration increases lung diffusing capacity in humans 201
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 199
Modification of arterial baroreflexes by captopril in essential hypertension 199
Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension 199
Heart failure and anemia: Effects on prognostic variables 197
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 197
Hemodynamic and Autonomic Response to Different Salt Intakes in Normotensive Individuals 196
Validation of the Somnotouch-NIBP noninvasive continuous blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010 194
Blood pressure and high altitude: physiological response and clinical management [Presión arterial y altitud: respuestas fisiológicas y manejo clínico] 194
Control of circulation by arterial baroreceptors and cardiopulmonary receptors in hypertension 191
Predicting Depression from Illness Severity in Cardiovascular Disease Patients: Self-efficacy Beliefs, Illness Perception, and Perceived Social Support as Mediators 190
[Are plasma catecholamine levels capable of reflecting even small variations in sympathetic activity?] 187
Circulating factors are involved in hypoxia-induced hepcidin suppression 186
Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude 186
Alerting reaction and rise in blood pressure during measurement by physician and nurse 186
A randomized and controlled study of noninvasive hemodynamicmonitoring as a guide to drug treatment of uncontrolled hypertensive patients 185
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: A meta-analysis 185
Control of blood pressure by carotid sinus baroreceptors in human beings 185
Prognostic value of baroreflex sensitivity in heart failure. A 2018 reappraisal 184
Vascular Health Assessment of The Hypertensive Patients (VASOTENS) Registry: Study Protocol of an International, Web-Based Telemonitoring Registry for Ambulatory Blood Pressure and Arterial Stiffness 183
Effects of device-guided slow breathing training on exercise capacity, cardiac function, and respiratory patterns during sleep in male and female patients with chronic heart failure 182
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison 182
Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude 181
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 181
The Added Value of 3-Dimensional Echocardiography to Understand the Pathophysiology of Functional Tricuspid Regurgitation 181
Obstructive sleep apnoea treatment and blood pressure: Which phenotypes predict a response? A systematic review and meta-analysis 181
Randomized Controlled Trials of Blood Pressure Lowering in Hypertension: A Critical Reappraisal 180
Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects 179
Intra-aortic balloon pump for treatment of refractory ventricular tachycardia in Tako-Tsubo cardiomyopathy: A case report 179
Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects 179
Recommendations and Practical Guidance for performing and reporting validation studies according to the Universal Standard for the validation of blood pressure measuring devices by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) 179
Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure 178
Effects of hypobaric hypoxia exposure at high altitude on left ventricular twist in healthy subjects: Data from HIGHCARE study on Mount Everest 177
Prevalence of hypertension and cardiovascular risk factors in chinese migrating to Milan as compared to a northern italian population 177
Reduction of 24-h blood pressure variability in extreme obese patients 10 days and 6 months after bariatric surgery depending on pre-existing hypertension 177
[Direct and continuous recording of arterial pressure in the diagnosis of pheochromocytoma] 176
Short-Term Repeatability of Noninvasive Aortic Pulse Wave Velocity Assessment: Comparison between Methods and Devices 176
Evaluation of relationship between cardio-ankle vascular index and 24h ambulatory blood pressure variables 175
Periodic limb movements during sleep and blood pressure changes in sleep apnoea: Data from the European Sleep Apnoea Database 175
Determinants of different blood pressure variability indices in untreated hypertensive patients. Data from the Dublin study 174
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 174
Clinical and psychological telemonitoring and telecare of high risk heart failure patients 174
Natriuretic peptides and cardiovascular variability 173
Isolated systolic hypertension in the young: A position paper endorsed by the European Society of Hypertension 173
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: A randomised controlled trial protocol 173
Pulmonary congestion at rest and abnormal ventilation during exercise in chronic systolic heart failure 171
Dynamic adaptation of cardiac baroreflex sensitivity to prolonged exposure to microgravity: data from 16-day spaceflight 170
High-altitude hypoxia and periodic breathing during sleep: gender related differences 169
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke 169
Intermittent levosimendan infusions in advanced heart failure: a real world experience 169
Impaired central pulsatile hemodynamics in children and adolescents with Marfan syndrome 169
Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure 168
Correlation between pulmonary artery pressure and thoracic impedance: Insights from daily monitoring through an implanted device in chronic heart failure 168
Neural Control of Circulation Before and After Intravenous Urapidil in Essential Hypertension 168
Totale 21.439
Categoria #
all - tutte 394.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 394.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011.053 0 0 0 0 1.410 2.086 2.143 1.330 1.571 1.005 1.074 434
2020/202115.317 967 759 1.600 1.602 1.140 1.364 1.581 1.547 1.371 1.428 737 1.221
2021/202211.977 750 1.116 1.755 955 812 626 659 684 634 798 1.160 2.028
2022/202316.265 2.161 4.384 1.536 1.295 1.065 2.714 208 845 1.064 196 448 349
2023/202412.180 352 463 432 498 1.785 3.168 2.304 306 1.110 223 207 1.332
2024/202511.230 1.930 3.850 1.525 1.415 2.510 0 0 0 0 0 0 0
Totale 101.157